Načítá se...
Discovery of a Highly Potent and Selective Indenoindolone Type 1 Pan-FLT3 Inhibitor
[Image: see text] For a subpopulation of acute myeloid leukemia (AML) patients, the mutationally activated tyrosine kinase FLT3, has emerged as a promising target for therapy. The development of drug resistance due to mutation is a growing concern for mutant FLT3 inhibitors, such as PKC412, Quizarti...
Uloženo v:
| Vydáno v: | ACS Med Chem Lett |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical
Society
2016
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4867484/ https://ncbi.nlm.nih.gov/pubmed/27190596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.5b00498 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|